Prevention and management of COVID-19 among patients with diabetes: an appraisal of the literature Prasad KatulandaHarsha A. DissanayakeDavid R. Matthews Review Open access 14 May 2020 Pages: 1440 - 1452
Exercising your fat (metabolism) into shape: a muscle-centred view Anne GemminkPatrick SchrauwenMatthijs K. C. Hesselink Review Open access 12 June 2020 Pages: 1453 - 1463
Exercise and metabolic health: beyond skeletal muscle John P. ThyfaultAudrey Bergouignan Review 11 June 2020 Pages: 1464 - 1474
The competitive athlete with type 1 diabetes Michael C. RiddellSam N. ScottRichard M. Bracken Review Open access 12 June 2020 Pages: 1475 - 1490
Train like an athlete: applying exercise interventions to manage type 2 diabetes Mladen SavikjJuleen R. Zierath Review Open access 11 June 2020 Pages: 1491 - 1499
Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study Bertrand CariouSamy Hadjadjfor the CORONADO investigators Article Open access 29 May 2020 Pages: 1500 - 1515
Adults with early-onset type 2 diabetes (aged 18–39 years) are severely underrepresented in diabetes clinical research trials Jack A. SargeantEmer M. BradyMelanie J. Davies Short Communication Open access 02 June 2020 Pages: 1516 - 1520
Pregnancy loss is associated with type 2 diabetes: a nationwide case–control study Pia EgerupAnders P. MikkelsenHenriette S. Nielsen Article 20 May 2020 Pages: 1521 - 1529
Temporal trends in diabetic ketoacidosis at diagnosis of paediatric type 1 diabetes between 2006 and 2016: results from 13 countries in three continents Valentino CherubiniJulia M. GrimsmannDana Dabelea Article Open access 08 May 2020 Pages: 1530 - 1541
Age-, sex- and ethnicity-related differences in body weight, blood pressure, HbA1c and lipid levels at the diagnosis of type 2 diabetes relative to people without diabetes Alison K. WrightPaul WelshNaveed Sattar Article Open access 21 May 2020 Pages: 1542 - 1553
Sex-specific associations of insulin resistance with chronic kidney disease and kidney function: a bi-directional Mendelian randomisation study Jie V. ZhaoC. Mary Schooling Article 15 May 2020 Pages: 1554 - 1563
Islet pericytes convert into profibrotic myofibroblasts in a mouse model of islet vascular fibrosis Luciana Mateus GonçalvesElizabeth PereiraJoana Almaça Article 18 May 2020 Pages: 1564 - 1575
Innate immune stimulation of whole blood reveals IFN-1 hyper-responsiveness in type 1 diabetes Kameron B. RodriguesMatthew J. DufortKristin V. Tarbell Article 05 June 2020 Pages: 1576 - 1587
Deletion of H-ferritin in macrophages alleviates obesity and diabetes induced by high-fat diet in mice Yasumasa IkedaHiroaki WatanabeToshiaki Tamaki Article 19 May 2020 Pages: 1588 - 1602
Treatment with a β-2-adrenoceptor agonist stimulates glucose uptake in skeletal muscle and improves glucose homeostasis, insulin resistance and hepatic steatosis in mice with diet-induced obesity Anastasia KalinovichNodi DehvariTore Bengtsson Article Open access 29 May 2020 Pages: 1603 - 1615
Complex interaction of fasting glucose, body mass index, age and sex on all-cause mortality: a cohort study in 15 million Korean adults Mi-Hyang JungSang-Wook YiHyeongsu Kim Article 19 May 2020 Pages: 1616 - 1625
Time trends in deaths before age 50 years in people with type 1 diabetes: a nationwide analysis from Scotland 2004–2017 Joseph E. O’ReillyLuke A. K. Blackbournfor the Scottish Diabetes Research Network Epidemiology Group Article Open access 26 May 2020 Pages: 1626 - 1636
Plasma fatty acids and the risk of vascular disease and mortality outcomes in individuals with type 2 diabetes: results from the ADVANCE study Katie HarrisMegumi OshimaMark Woodward Article Open access 08 May 2020 Pages: 1637 - 1647
Cardiometabolic risk factors as determinants of peripheral nerve function: the Maastricht Study Jeroen H. P. M. van der VeldeAnnemarie KosterNicolaas C. Schaper Article Open access 15 June 2020 Pages: 1648 - 1658
Sufficient increment of sulfonylurea without reintroduction of insulin ameliorates pubertal deterioration of glycaemic control in KCNJ11 neonatal diabetes treated with long-term sulfonylurea Shigeru SuzukiTokuo MukaiHiroshi Azuma Research Letter 24 May 2020 Pages: 1659 - 1661
Diabetic retinopathy: looking beyond the eyes Rafael SimóCoen D. A. StehouwerAngelo Avogaro Letter 18 June 2020 Pages: 1662 - 1664
Why is the presence of autoantibodies against GAD associated with a relatively slow progression to clinical diabetes? Anette-Gabriele ZieglerEzio Bonifacio Letter Open access 26 May 2020 Pages: 1665 - 1666
Correction to: 2019 update to: Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of diabetes (EASD) John B. BuseDeborah J. WexlerMelanie J. Davies Correction 15 May 2020 Pages: 1667 - 1667